Medication info

Hyaluronic Injection 1% (Sodium Hyaluronate)

Prescription medicationInjectionsInjection
Ingredient · strength
Sodium Hyaluronate›10mg / 1mL
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
A colorless, transparent, viscous solution contained in a colorless and transparent prefilled syringe capped with a rubber stopper.
Packaging
1 prefilled syringe per box [prefilled syringe (0.85 mL)]
Approval status
Active

MFDS item code 201004256 · Notified 2010.06.30 · Insurance code 643505641

Summary

Main use
Adjunctive treatment in ophthalmic surgery (cataract, corneal transplantation, glaucoma, etc.)
Who receives it
Adults
Adult administration
1. Cataract surgery and intraocular lens implantation: Slowly inject the required amount of this medicine into the anterior chamber through a needle or cannula, before or after lens removal. Inject before cataract extraction and intraocular lens implantation to optimize its adjuvant corneal endothelial protective effect; therefore, inject before intracapsular or extracapsular cataract surgery. This medicine may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation: After removing the corneal graft, fill the anterior chamber with this medicine until it is level with the corneal surface. Place the donor graft on this medicine and suture it in place. 3. Glaucoma filtration surgery: Inject this medicine through a corneal paracentesis to supplement and maintain anterior chamber volume during trabeculectomy.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunctive treatment in ophthalmic surgery (cataract, corneal transplantation, glaucoma, etc.)

View approved original text

This medication is used to assist in various ophthalmic surgeries such as intraocular lens implantation after cataract surgery, corneal transplantation, and glaucoma surgery.

How it is given

Adult administration

1. Cataract surgery and intraocular lens implantation: Slowly inject the required amount of this medicine into the anterior chamber through a needle or cannula, before or after lens removal. Inject before cataract extraction and intraocular lens implantation to optimize its adjuvant corneal endothelial protective effect; therefore, inject before intracapsular or extracapsular cataract surgery. This medicine may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation: After removing the corneal graft, fill the anterior chamber with this medicine until it is level with the corneal surface. Place the donor graft on this medicine and suture it in place. 3. Glaucoma filtration surgery: Inject this medicine through a corneal paracentesis to supplement and maintain anterior chamber volume during trabeculectomy.

Precautions

This medication should not be used in patients with hypersensitivity to protein-based drugs or to any component of this product. Ocular side effects may include temporary increase in intraocular pressure, and rarely may cause inflammation, corneal edema, corneal opacity, bleeding, vascular abnormalities of the iris, pain, itching, and vision loss. There is also a possibility of developing opacification on the surface of the intraocular lens, and as it contains phosphate components, very rarely, calcification of the cornea may occur in patients with severe corneal damage. Immediately after surgery, intraocular pressure should be monitored closely, and if an increase occurs, appropriate treatment is necessary. Postoperatively, it is recommended to clean or aspirate this medication, and prior to ultrasonic emulsification aspiration, it is advisable to create a space between the lens and this medication with an irrigating solution. Solutions containing quaternary ammonium compounds, such as benzalkonium chloride, should not be used to clean surgical instruments. This product should not be used in conjunction with hyaluronidase, is for ophthalmic use only, and must never be injected intravascularly. When using, the refrigerated medication should be allowed to sit at room temperature for about 30 minutes before use, and any unused portion should be discarded after one use. During injection, care should be taken to prevent air from entering beneath the iris, and it should be administered slowly, as excessive injection may cause an increase in intraocular pressure. Caution is advised. While storing, keep out of reach of children, avoid direct sunlight, and store sealed in a cool, dry place.

Side effects

Increased intraocular pressure, inflammatory response, corneal edema, corneal opacity, anterior hemorrhage, iris neovascularization, posterior iris ulcer, conjunctival adhesion deficiency, mydriasis, lens opacity, pain, pruritus, blurred vision, corneal functional disorder, opacification of intraocular lens surface, corneal calcification

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a light-protective, airtight container. Additionally, it is important to store it at a refrigerated temperature between 2°C and 8°C to maintain freshness.

Appearance and packaging

Appearance

A colorless, transparent, viscous solution contained in a colorless and transparent prefilled syringe capped with a rubber stopper.

Package unit

1 prefilled syringe per box [prefilled syringe (0.85 mL)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.